Cargando…
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction is responsible for half of all heart failure and confers substantial morbidity and mortality, and yet to date, there have been no effective pharmacologic interventions. Although the pathophysiology is complex, the primary aetiology of exercise intoleran...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941219/ https://www.ncbi.nlm.nih.gov/pubmed/35438418 http://dx.doi.org/10.1007/s10741-022-10236-8 |